Rethinking Weight Loss: The Science Behind GLP-1 Medications episode artwork

EPISODE · Aug 13, 2026 · 6 MIN

Rethinking Weight Loss: The Science Behind GLP-1 Medications

from Rethinking Weight Loss: The Science Behind GLP-1 Medications

In this episode, I explore the growing impact of GLP-1 medications on weight management and overall health. Once developed to help manage type 2 diabetes, medications such as Ozempic, Wegovy, and Mounjaro have transformed conversations about obesity and weight loss. I'll discuss how these medications work in the body, why they help regulate appetite and blood sugar, and what current research reveals about their effectiveness. I'll also examine common misconceptions, potential side effects, and the broader implications for public health. Join me as I take a closer look at the science behind GLP-1 medications and how they are changing the future of weight loss treatment.

Episode metadata supplied by the publisher feed · Published Aug 13, 2026

Embed this episode

Ready to play

Rethinking Weight Loss: The Science Behind GLP-1 Medications

0:00 6:51

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Rethinking Weight Loss: The Science Behind GLP-1 Medications?

This episode is 6 minutes long.

When was this Rethinking Weight Loss: The Science Behind GLP-1 Medications episode published?

This episode was published on August 13, 2026.

Can I download this Rethinking Weight Loss: The Science Behind GLP-1 Medications episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!